Fertility Counseling in Survivors of Cancer in Childhood and Adolescence: Time for a Reappraisal?
adoption
cancer survivors
fertility preservation
genetics
hereditary cancer syndrome
infertility
oocyte donation
preimplantation genetic testing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
10 Nov 2021
10 Nov 2021
Historique:
received:
05
09
2021
revised:
03
11
2021
accepted:
05
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Genetic predisposition could have an important role in the pathogenesis of cancers in children and adolescents. A recent study by our group showed that, among female survivors of cancers in childhood and adolescence, the proportion of cases involving a possible genetic predisposition was sizable (at least one in five). Our sample is too small to be representative of the general population, but it gave us an opportunity to reappraise this issue. Women with a genetic predisposition can transmit the risk of cancer to their offspring, and their awareness of this may influence their reproductive and fertility preservation choices. In our experience, a predisposition to cancer receives little attention in the fertility counseling and decision-making process unless a patient already has a definitive molecular diagnosis of a hereditary cancer syndrome. We feel it is essential to empower women on this issue, particularly as there are ways to overcome the problem, including preimplantation genetic testing (PGT-M) in definitively diagnosed cases, egg donation and adoption. In the context of fertility counseling for survivors of cancer in childhood and adolescence who have reached adulthood, the risk of transmitting a predisposition to cancer should be discussed with patients, if relevant and desired.
Identifiants
pubmed: 34830781
pii: cancers13225626
doi: 10.3390/cancers13225626
pmc: PMC8615855
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Cancer Surviv. 2021 Feb;15(1):54-65
pubmed: 32613442
Future Oncol. 2018 Feb;14(5):483-490
pubmed: 29327596
Support Care Cancer. 2020 Oct;28(10):4857-4867
pubmed: 31993754
Eur J Cancer Care (Engl). 2010 Sep;19(5):610-20
pubmed: 20088919
Tumori. 2016 Mar-Apr;102(2):174-7
pubmed: 26689666
Fertil Steril. 2018 Jun;109(6):989-992
pubmed: 29935659
J Adolesc Young Adult Oncol. 2020 Oct;9(5):572-578
pubmed: 32320315
Hum Reprod. 2015 Sep;30(9):2011-3
pubmed: 26202919
Fertil Steril. 2021 Oct;116(4):1087-1095
pubmed: 34238574
Ups J Med Sci. 2020 May;125(2):175-182
pubmed: 31802698
JAAPA. 2020 Dec;33(12):10-16
pubmed: 33234888
Lancet Oncol. 2021 Feb;22(2):e45-e56
pubmed: 33539753
Pediatr Blood Cancer. 2019 Jun;66(6):e27668
pubmed: 30815985
J Cancer Surviv. 2021 Apr;15(2):259-272
pubmed: 32844376
Pediatr Blood Cancer. 2020 Jul;67(7):e28335
pubmed: 32391946
Surg Clin North Am. 2020 Jun;100(3):483-498
pubmed: 32402295
J Clin Oncol. 2021 Oct 10;39(29):3195-3198
pubmed: 34473566
Am J Med Genet A. 2017 Apr;173(4):1017-1037
pubmed: 28168833
Hum Reprod Update. 2019 Mar 1;25(2):159-179
pubmed: 30462263
Reprod Biomed Online. 2019 Aug;39(2):179-181
pubmed: 31279716